362 related articles for article (PubMed ID: 17127261)
1. Roles of transglutaminases in cardiac and vascular diseases.
Sane DC; Kontos JL; Greenberg CS
Front Biosci; 2007 Jan; 12():2530-45. PubMed ID: 17127261
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Reveals Distinct Roles for Tissue Transglutaminase and Factor XIII in Maternal Angiogenesis During Early Mouse Pregnancy.
Cohen G; Hadas R; Stefania R; Pagoto A; Ben-Dor S; Kohen F; Longo D; Elbaz M; Dekel N; Gershon E; Aime S; Neeman M
Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1602-1613. PubMed ID: 31189431
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.
Griffin KJ; Newell LM; Simpson KR; Beckers CML; Drinkhill MJ; Standeven KF; Cheah LT; Iismaa SE; Grant PJ; Jackson CL; Pease RJ
Atherosclerosis; 2020 Feb; 294():1-9. PubMed ID: 31874419
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues.
Greenberg CS; Birckbichler PJ; Rice RH
FASEB J; 1991 Dec; 5(15):3071-7. PubMed ID: 1683845
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase and factor XIII in cartilage and bone remodeling.
Aeschlimann D; Mosher D; Paulsson M
Semin Thromb Hemost; 1996; 22(5):437-43. PubMed ID: 8989828
[TBL] [Abstract][Full Text] [Related]
7. Tissue transglutaminase (TG2)--a wound response enzyme.
Telci D; Griffin M
Front Biosci; 2006 Jan; 11():867-82. PubMed ID: 16146777
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses.
D'Eletto M; Farrace MG; Piacentini M; Rossin F
Methods Enzymol; 2017; 587():511-520. PubMed ID: 28253975
[TBL] [Abstract][Full Text] [Related]
9. The role of transglutaminase-2 and its substrates in human diseases.
Facchiano F; Facchiano A; Facchiano AM
Front Biosci; 2006 May; 11():1758-73. PubMed ID: 16368554
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous activity assay of two transglutaminase isozymes, blood coagulation factor XIII and transglutaminase 2, by use of fibrinogen arrays.
Kwon MH; Jung SH; Kim YM; Ha KS
Anal Chem; 2011 Nov; 83(22):8718-24. PubMed ID: 21961727
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis.
Bakker EN; Pistea A; VanBavel E
J Vasc Res; 2008; 45(4):271-8. PubMed ID: 18212504
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 inhibitors and their therapeutic role in disease states.
Siegel M; Khosla C
Pharmacol Ther; 2007 Aug; 115(2):232-45. PubMed ID: 17582505
[TBL] [Abstract][Full Text] [Related]
13. Factor XIII (FXIII) and angiogenesis.
Dardik R; Loscalzo J; Inbal A
J Thromb Haemost; 2006 Jan; 4(1):19-25. PubMed ID: 16129024
[TBL] [Abstract][Full Text] [Related]
14. Regulation of transglutaminases by nitric oxide.
Bernassola F; Rossi A; Melino G
Ann N Y Acad Sci; 1999; 887():83-91. PubMed ID: 10668466
[TBL] [Abstract][Full Text] [Related]
15. [Multiple functions of transglutaminases].
Hasegawa G; Saito Y
Tanpakushitsu Kakusan Koso; 2004 Apr; 49(5):642-8. PubMed ID: 15071895
[No Abstract] [Full Text] [Related]
16. Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
Grosso H; Mouradian MM
Pharmacol Ther; 2012 Mar; 133(3):392-410. PubMed ID: 22212614
[TBL] [Abstract][Full Text] [Related]
17. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
Colak G; Keillor JW; Johnson GV
PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
[TBL] [Abstract][Full Text] [Related]
19. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
Achyuthan KE; Dobson JV; Greenberg CS
Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
